Literature DB >> 3139338

Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment.

D Carr1, D T McLeod, G Parry, H M Thornes.   

Abstract

Thyroxine replacement therapy for 21 adult patients with primary hypothyroidism was adjusted to the dosage at which each patient had a normal thyrotrophin (TSH) response to thyrotrophin releasing hormone (TRH). Clinical assessment and measurement of TSH (by sensitive immunoradiometric assay), free thyroxine (FT4) and free tri-iodothyronine (FT3) were made at this dosage and at higher and lower doses of thyroxine. Clinical observations, FT3 and FT4 assays were relatively insensitive to small alterations of thyroxine dosage, in contrast to which basal TSH measurements correlated well with TRH responsiveness and were sensitive to fine adjustments of thyroxine dosage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139338     DOI: 10.1111/j.1365-2265.1988.tb01219.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  32 in total

Review 1.  Management of the unexpected result: compensated hypothyroidism.

Authors:  R Benediktsson; A D Toft
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

2.  Thyroid function tests and hypothyroidism.

Authors:  Anthony D Toft; Geoffrey J Beckett
Journal:  BMJ       Date:  2003-02-08

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.

Authors:  N Yannovits; E Zintzaras; A Pouli; G Koukoulis; S Lyberi; E Savari; S Potamianos; F Triposkiadis; I Stefanidis; E Zartaloudis; A Benakis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

Review 5.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

6.  The secretion of human growth hormone stimulated by human growth hormone releasing factor following severe cranio-cerebral trauma.

Authors:  M Gottardis; C Nigitsch; E Schmutzhard; M Neumann; C Putensen; J M Hackl; W Koller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy.

Authors:  M Luisa Isidro; Manuel A Penín; Rosa Nemiña; Fernando Cordido
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

8.  Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis.

Authors:  M H Samuels; K G Schuff; N E Carlson; P Carello; J S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

9.  Dyslipidaemic changes in women with subclinical hypothyroidism.

Authors:  N Karthick; K Dillara; K N Poornima; A S Subhasini
Journal:  J Clin Diagn Res       Date:  2013-10-05

10.  The History and Future of Treatment of Hypothyroidism.

Authors:  Elizabeth A McAninch; Antonio C Bianco
Journal:  Ann Intern Med       Date:  2016-01-05       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.